Johnson & Johnson / Shionogi Pharmaceuticals / Pfizer / GlaxoSmithKline / Merck / Abbott Labs / Schering / /
Continent
America / Europe / /
Country
United States / Brazil / Canada / /
Currency
USD / / /
Event
Business Partnership / FDA Phase / /
Facility
Efavirenz Side Effects Anti-HIV Pipeline / HIV factory / Institute of Human Virology / Integrase Inhibitors Anti-HIV Pipeline / University of Baltimore / /
IndustryTerm
advertising dollars / healthcare plan / AIDS Treatment / discussed solutions / pharmaceutical industry / fundamental tool / healthcare emergencies / large networks / grant applications / HIV Therapy / Possible solutions / healthcare / healthcare systems / HIV treatment / treatment of HIV disease / retail store / health product / pharmaceuticals / healthcare system / study site / internet pharmacies / malpractice insurance costs / manufacturing / chemical structure / Therapy for HIV / /
National Institute of Health / Food and Drug Administration / US government / Foundation for AIDS / Federal Guidelines Committee / University of Baltimore / World Trade Organization / Medicare / Congress / Immune Research / White House / Scientific Advisory Board / FDA / Division of AIDS / NIH’s office of AIDS Research / Institute of Human Virology / Veterans Administration / /
Person
Robert Gallo / / /
Position
president / Executive / representative / /
Product
Efavirenz / Schering D / Fuzeon / nevirapine / HIV Drug / Kaletra / Reyataz / this / D4FC / S-1360 / /
ProvinceOrState
California / /
Technology
cell receptors / antibodies / Gene Therapy / Drug Delivery / drug development / /